| Date Filed | Type | Description |
| 08/17/2021 |
4
| Stylli Harry (Chairman & CEO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 10,335 shares
@ $1.66, valued at
$17.2k
|
|
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Stylli Harry (Chairman & CEO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 8,615 shares
@ $6.32, valued at
$54.4k
|
|
| 12/04/2020 |
4
| Stylli Harry (Chairman & CEO) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Bought 152,905 shares
@ $3.27, valued at
$500k
|
|
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/17/2010 |
4
| Stylli Harry (Director) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 05/14/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2009 |
4
| Stylli Harry (President and CEO) has filed a Form 4 on SEQUENOM INC |
| 02/17/2009 |
4
| Stylli Harry (President and CEO) has filed a Form 4 on SEQUENOM INC |
| 01/20/2009 |
4
| Stylli Harry (President and CEO) has filed a Form 4 on SEQUENOM INC |
| 03/19/2008 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |